Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.
about
Characterization of differential antibody production against hepatitis C virus in different HCV infection statusAutomated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosisGenetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis unitsAnalysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles.Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients.Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNAQuantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes.Antibodies to hepatitis C virus in essential mixed cryoglobulinaemiaAntigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 proteinTesting for hepatitis C virusManaging chronic hepatitis C virus infectionThe natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infectionViral hepatitis and the surgeonHepatitis C virus infection in Iceland: a recently introduced blood-borne diseaseStudy on reliability of commercially available hepatitis C virus antibody testsIndeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypesEvaluation of performance of the RIBA processor system for automated analysis of the strip immunoblot assay for detection of antibodies to hepatitis C virusSignificance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibodyInduction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinInvestigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassayProspective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donorsCorrelation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression systemSignificance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBAEvaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigenEffects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virusDetection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reactionUse of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratoryVirological features of hepatitis C virus infection in hemodialysis patientsEvaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virusStorage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virusADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum.Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection.Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis CHigh dose interferon treatment in chronic hepatitis C.Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus
P2860
Q27469004-45444713-163B-47ED-B423-8ACDEE736699Q27469384-A29FEE79-B5B7-4F8A-B382-91BF90155645Q27469408-BB1BB0F7-4C16-4290-9975-A277DCC0D501Q27469551-8F3ADF4C-0673-4FC3-A953-FB3F8C8B099BQ27472875-392B6A1C-13A3-4C25-ADAA-DDA5A1FE9D57Q27472995-573FE0DB-51D5-4AF5-956E-BF2754548BFDQ27472996-CE6C4A35-9DE9-41CC-AB5E-74947D1055BCQ27472999-E8947DF4-DF1E-4767-9270-26D1B31622AAQ27473016-6C1EDE87-81E2-46C9-B10F-5529803CF4C6Q27473019-3709F2B3-4266-4372-A965-D58AA77AD294Q27473547-3633D38D-5E56-4E63-B2BC-7E9F3704B775Q27473552-45643C01-C37B-4DAF-8F63-8389CB5E6DFAQ27477700-B698166D-85AE-4463-856C-F1DF5CB6B8B2Q27477721-10E092EB-DE0D-4DAB-9F19-DA631BD085A4Q27477855-8A9E25E2-C802-4EEE-B6C8-B0AC35C9EA24Q27481282-F14CDE18-F9C8-46A6-8AB4-4E1CD7950DFDQ27485597-38E01ADB-EE35-43A0-80B6-A0AECE733A91Q27485647-6FF541CE-61F2-4340-B6CA-EE75416DC70FQ27485774-2C9B944C-4A56-4167-87D2-9B33EF38D626Q27485785-F9DE1D94-3FD3-4B35-8341-33C25BD34AC9Q27485923-4F960A26-B1CD-4E66-A08F-258E29EA1A8DQ27486239-11CFAB18-BCBD-4A00-A2A9-19EB5A7281ACQ27487574-37644AD8-5575-41A3-939D-D3B6B77EF580Q27487581-70973ED5-9272-4FE4-B519-2C64731FCC57Q27487757-6251324E-B8AB-45D4-9882-79BDE6A57B2BQ27487871-9382F900-1271-45C2-9FA9-D7700D14868EQ27487889-AD8CE1E1-C2AA-4607-A8B7-C020BDCD1259Q27487987-F398E37A-C16A-4F54-8533-13E8D6066356Q27488101-4ABDC965-2CB2-42B3-B2C0-C57FBEF8690EQ27488204-2D3C672F-3761-4D66-8B66-7E941B6E2E1BQ27488263-4DC1AB31-8FC2-4532-97CD-1239B79DC8DCQ27488857-F5640086-4E20-4F09-A31B-C37D3DFDB392Q27488873-CAD765AE-F3AF-46F4-8CA1-58A59123080AQ31006433-BDCB6546-4936-4A61-9A86-3E44D2DF8FDBQ33197162-63B6C8D5-FF83-47A8-910D-91C0D8973185Q33612002-3C0A05C3-D6A1-4E18-9459-8AECAD10ECBCQ33959072-325D31B6-0349-4313-86D4-3023EF601587Q34225261-19AC5C19-42F3-4409-8AAF-415AFB2802B0Q34375842-9EF3E58B-8DA1-443B-8492-CFE29C4C2A30Q34875792-E55B39AE-EF84-4946-BA4F-ECA276AC8228
P2860
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@en
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@nl
type
label
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@en
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@nl
prefLabel
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@en
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@nl
P2093
P1433
P1476
Confirmation of hepatitis C vi ...... recombinant immunoblot assay.
@en
P2093
A J Weiner
C L Van der Poel
D Mulder-Folkerts
H T Cuypers
H W Reesink
J J Van Boven
P J Exel-Oehlers
R Di Nello
P304
P356
10.1016/0140-6736(91)90942-I
P407
P577
1991-02-01T00:00:00Z